Transgenic swine: expression of human CD39 protects against myocardial injury.
about
Kidney xenotransplantationImmune modulation in xenotransplantationCardiac purinergic signalling in health and diseaseImmunobiology of liver xenotransplantation.Generation of α-1,3-galactosyltransferase knocked-out transgenic cloned pigs with knocked-in five human genesComplete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient miceHistopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejectionThe production of multi-transgenic pigs: update and perspectives for xenotransplantation.Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In VitroJuvenile Swine Surgical Alveolar Cleft Model to Test Novel Autologous Stem Cell TherapiesEctonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activitiesCurrent status of pig heart xenotransplantation.Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?Efficient production of multi-modified pigs for xenotransplantation by 'combineering', gene stacking and gene editing.Cardioprotective effects of adenosine within the border and remote areas of myocardial infarctionAssessment of fecundity and germ line transmission in two transgenic pig lines produced by sleeping beauty transposition.Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein.The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.Transplantation of xenogeneic islets: are we there yet?CD39: Interface between vascular thrombosis and inflammation.Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.Genetically Modified Pigs as Organ Donors for Xenotransplantation.Production and Breeding of Transgenic Cloned Pigs Expressing Human CD73.siRNA mediated knockdown of tissue factor expression in pigs for xenotransplantation.ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon modelOptimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation.Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate?Production of heterozygous alpha 1,3-galactosyltransferase (GGTA1) knock-out transgenic miniature pigs expressing human CD39.Comparison of the expression of cluster of differentiation (CD)39 and CD73 between propofol- and sevoflurane-based anaesthesia during open heart surgery.Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation
P2860
Q26822638-CB29EF86-89E0-44BE-9E1C-316573FF1FA6Q26826905-4F1F80C8-E1A1-4633-B879-24822A06B47CQ33165093-5802BDBA-EDD6-47F1-8D3F-7AACE1F3D0BAQ33403888-24546EB3-0C95-4CF2-B826-56F88BA2DD35Q33434800-7B039CBC-C816-424E-98E4-2B80507DE30DQ33867669-52ACA16F-C763-42DB-A673-F78957CBFE23Q34018912-DEAAC480-FE21-422E-B766-3003FEF5E807Q34045996-745CFB52-4018-4EFF-8713-4A5D8CDEEFB1Q35826059-53115570-B279-4BB8-84AC-4E1670357DFFQ36006836-0B7E522B-A699-475B-B851-1E5436C797C4Q36071796-75087A3F-F0B7-4163-89BC-A6ED5DE03A96Q36183732-EAB2E83D-3933-4475-BE97-ED599FA4E7C3Q36386394-EDB13740-1DF3-4B66-A880-463E947110AAQ36779378-AA9A24B8-1D53-443B-A965-51D2493FF812Q37050158-08757223-528F-4BD4-A6AC-D529F2324BB2Q37356878-F1A0D157-C5E9-4B47-B420-03740FCB2DAFQ37508177-2BD27A0F-2942-436A-A8E8-A7347E237751Q37519520-BCDC42E3-C0B1-4ADC-BD0B-4569DA1CBC44Q38063159-362D0C9D-AA52-4A7A-AF87-E2AD7724C91CQ38127152-314B2D43-BBB7-44A9-A0A7-4C79F00D20B8Q38212581-CB4A616D-DAE7-4BC1-9895-E9777A0EBBD1Q38901709-E7E55577-0591-4649-9CEF-E7525CF8B82FQ39429841-5FDE29E7-1B98-4053-B0CA-22A8E3B32565Q41159327-AA13C68B-722A-4F70-9B19-92B9D99384A3Q41161110-8BBAA035-63B8-48B4-8BE9-9AFAD3689B92Q41628315-7C4C65C7-75C8-436F-B7B7-E1A4B9050D4CQ41723730-C946A074-1117-4B9F-A160-57DB6C682FE5Q43102079-3234FC25-EEFF-43E4-9810-E4038D570D34Q44770974-CA03E922-2238-4D1C-81E7-7D9059C582E4Q47136558-38A767CD-6A5A-4D3D-BDEC-59113DE89BA4Q48938785-FA585256-7C4A-4283-83B9-ACAFCC5B4D98Q55618915-234CB9F4-3BAF-4B2A-B22E-F033D6C76CB6Q58762883-7A712387-1AB7-4968-AB17-D79CECB16C72
P2860
Transgenic swine: expression of human CD39 protects against myocardial injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Transgenic swine: expression of human CD39 protects against myocardial injury.
@ast
Transgenic swine: expression of human CD39 protects against myocardial injury.
@en
type
label
Transgenic swine: expression of human CD39 protects against myocardial injury.
@ast
Transgenic swine: expression of human CD39 protects against myocardial injury.
@en
prefLabel
Transgenic swine: expression of human CD39 protects against myocardial injury.
@ast
Transgenic swine: expression of human CD39 protects against myocardial injury.
@en
P2093
P2860
P1476
Transgenic swine: expression of human CD39 protects against myocardial injury.
@en
P2093
Anthony J F d'Apice
Debra G Wheeler
Karen M Dwyer
Mark B Nottle
Matthew E Joseph
Peter J Cowan
Peter J Mohler
Richard J Gumina
Sharon J Harrison
Shouvik D Mahamud
P2860
P304
P356
10.1016/J.YJMCC.2012.01.002
P577
2012-01-12T00:00:00Z